United States Continuous Glucose Monitors Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.4 Billion by 2030, growing at a CAGR of 9.7% from 2024 to 2030.
The U.S. Continuous Glucose Monitors (CGM) market has experienced significant growth in recent years, driven by the increasing prevalence of diabetes and advancements in medical technology. As someone who has closely followed this industry, I've observed how these devices have transformed diabetes management, offering real-time insights into blood glucose levels and reducing the need for frequent fingerstick tests.
In 2023, the U.S. CGM market was valued at approximately $1.51 billion and is projected to grow at a compound annual growth rate (CAGR) of 6.68% from 2024 to 2030. This growth can be attributed to factors such as the rising number of diabetes cases, an aging population, and the development of more user-friendly CGM devices. Notably, the U.S. accounted for a 33% revenue share of the global market in 2023, highlighting its dominance in this sector. citeturn0search0
From my perspective, the market offers a variety of CGM devices catering to different user needs. The primary components of these systems include sensors, transmitters, and receivers. Sensors, inserted just below the skin, continuously monitor glucose levels. Transmitters send this data to receivers or compatible smart devices, allowing users to track their glucose levels in real-time. Among these, transmitters and receivers represented the largest revenue-generating segment in 2022, capturing a 36.9% market share. citeturn0search2
In my experience, the homecare segment has emerged as a significant end-user of CGM devices. In 2023, this segment held the largest revenue share at 46.7% and is anticipated to witness the highest CAGR of 7.73% during the forecast period. The convenience of monitoring glucose levels at home without frequent hospital visits has made CGMs particularly appealing to patients. citeturn0search3
Industry requirements have evolved to meet the demands of both patients and healthcare providers. Accuracy remains paramount, as precise glucose readings are essential for effective diabetes management. Additionally, ease of use is crucial; devices that are user-friendly encourage consistent monitoring, leading to better health outcomes. Integration capabilities with other medical devices and health platforms have also become a key requirement, allowing for a more holistic approach to patient care.
Reflecting on recent developments, companies like Abbott Laboratories and Dexcom have made notable strides. Abbott's medical devices unit achieved $4.75 billion in sales for the third quarter, surpassing analysts' predictions of $4.68 billion. The rising demand for glucose monitors like FreeStyle Libre, influenced by heightened diabetes care awareness and improved insurance coverage, played a significant role. citeturn0news20
Dexcom's launch of the Stelo CGM, designed for individuals with type 2 diabetes who don't require insulin, marks a significant milestone. Priced at $99 monthly for two 15-day sensors or $89 for a subscription model, Stelo aims to provide real-time blood sugar tracking and insights via a smartphone app. This product targets the 125 million Americans with prediabetes or type 2 diabetes not on insulin, reflecting the industry's shift towards making CGMs more accessible to a broader audience. citeturn0news22
In summary, the U.S. Continuous Glucose Monitors market is on an upward trajectory, driven by technological advancements and a growing need for effective diabetes management solutions. The industry's focus on accuracy, user-friendliness, and integration capabilities aligns with the evolving requirements of both patients and healthcare providers, promising a future where diabetes care is more efficient and patient-centric.
Get an In-Depth Research Analysis of the US Continuous Glucose Monitors Market Size And Forecast [2025-2032]
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Continuous Glucose Monitors Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Continuous Glucose Monitors Market
Real-Time Continuous Glucose Monitors (RT-CGMs)
Professional Continuous Glucose Monitors
Flash Continuous Glucose Monitoring Systems
Hospitals and Clinics
Home Care Settings
Nursing Homes
Type 1 Diabetes Management
Type 2 Diabetes Management
Gestational Diabetes Management
Other Clinical Applications
Invasive Glucose Monitoring Technology
Non-Invasive Glucose Monitoring Technology
Wearable Sensors and Patches
Online Pharmacies
Retail Pharmacies
Medical Supply Stores
Direct Sales
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Continuous Glucose Monitors Market Research Analysis
1. Introduction of the US Continuous Glucose Monitors Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Continuous Glucose Monitors Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Continuous Glucose Monitors Market, By Type
6. US Continuous Glucose Monitors Market, By Application
7. US Continuous Glucose Monitors Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Continuous Glucose Monitors Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/